244 related articles for article (PubMed ID: 17131317)
1. CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study.
Palli D; Masala G; Del Giudice G; Plebani M; Basso D; Berti D; Numans ME; Ceroti M; Peeters PH; Bueno de Mesquita HB; Buchner FL; Clavel-Chapelon F; Boutron-Ruault MC; Krogh V; Saieva C; Vineis P; Panico S; Tumino R; Nyrén O; Simán H; Berglund G; Hallmans G; Sanchez MJ; Larrãnaga N; Barricarte A; Navarro C; Quiros JR; Key T; Allen N; Bingham S; Khaw KT; Boeing H; Weikert C; Linseisen J; Nagel G; Overvad K; Thomsen RW; Tjonneland A; Olsen A; Trichoupoulou A; Trichopoulos D; Arvaniti A; Pera G; Kaaks R; Jenab M; Ferrari P; Nesi G; Carneiro F; Riboli E; Gonzalez CA
Int J Cancer; 2007 Feb; 120(4):859-67. PubMed ID: 17131317
[TBL] [Abstract][Full Text] [Related]
2. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity.
Kamangar F; Dawsey SM; Blaser MJ; Perez-Perez GI; Pietinen P; Newschaffer CJ; Abnet CC; Albanes D; Virtamo J; Taylor PR
J Natl Cancer Inst; 2006 Oct; 98(20):1445-52. PubMed ID: 17047193
[TBL] [Abstract][Full Text] [Related]
3. A CagA-independent cluster of antigens related to the risk of noncardia gastric cancer: associations between Helicobacter pylori antibodies and gastric adenocarcinoma explored by multiplex serology.
Song H; Michel A; Nyrén O; Ekström AM; Pawlita M; Ye W
Int J Cancer; 2014 Jun; 134(12):2942-50. PubMed ID: 24259284
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori seropositivity and subsite-specific gastric cancer risks in Linxian, China.
Limburg P; Qiao Y; Mark S; Wang G; Perez-Perez G; Blaser M; Wu Y; Zou X; Dong Z; Taylor P; Dawsey S
J Natl Cancer Inst; 2001 Feb; 93(3):226-33. PubMed ID: 11158192
[TBL] [Abstract][Full Text] [Related]
5. Interactions between pork consumption, CagA status and IL-1B-31 genotypes in gastric cancer.
Wang XQ; Terry PD; Cheng L; Yan H; Wang JS; Wu WA; Hu SK
World J Gastroenterol; 2014 Jul; 20(25):8151-7. PubMed ID: 25009387
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: the Eurgast-EPIC project.
González CA; Megraud F; Buissonniere A; Lujan Barroso L; Agudo A; Duell EJ; Boutron-Ruault MC; Clavel-Chapelon F; Palli D; Krogh V; Mattiello A; Tumino R; Sacerdote C; Quirós JR; Sanchez-Cantalejo E; Navarro C; Barricarte A; Dorronsoro M; Khaw KT; Wareham N; Allen NE; Tsilidis KK; Bas Bueno-de-Mesquita H; Jeurnink SM; Numans ME; Peeters PHM; Lagiou P; Valanou E; Trichopoulou A; Kaaks R; Lukanova-McGregor A; Bergman MM; Boeing H; Manjer J; Lindkvist B; Stenling R; Hallmans G; Mortensen LM; Overvad K; Olsen A; Tjonneland A; Bakken K; Dumeaux V; Lund E; Jenab M; Romieu I; Michaud D; Mouw T; Carneiro F; Fenge C; Riboli E
Ann Oncol; 2012 May; 23(5):1320-1324. PubMed ID: 21917738
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia.
Ye W; Held M; Lagergren J; Engstrand L; Blot WJ; McLaughlin JK; Nyrén O
J Natl Cancer Inst; 2004 Mar; 96(5):388-96. PubMed ID: 14996860
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of
Fernandez-Botran R; Wellmann IA; Une C; Méndez-Chacón E; Hernández de Rodas E; Bhandari B; Villagrán de Tercero CI
Am J Trop Med Hyg; 2020 Jul; 103(1):260-265. PubMed ID: 32314688
[TBL] [Abstract][Full Text] [Related]
9. Association of helicobacter pylori infection and chronic atrophic gastritis with risk of colonic, pancreatic and gastric cancer: A ten-year follow-up of the ESTHER cohort study.
Chen XZ; Schöttker B; Castro FA; Chen H; Zhang Y; Holleczek B; Brenner H
Oncotarget; 2016 Mar; 7(13):17182-93. PubMed ID: 26958813
[TBL] [Abstract][Full Text] [Related]
10. Multiplex H. pylori Serology and Risk of Gastric Cardia and Noncardia Adenocarcinomas.
Shakeri R; Malekzadeh R; Nasrollahzadeh D; Pawlita M; Murphy G; Islami F; Sotoudeh M; Michel A; Etemadi A; Waterboer T; Poustchi H; Brennan P; Boffetta P; Dawsey SM; Kamangar F; Abnet CC
Cancer Res; 2015 Nov; 75(22):4876-83. PubMed ID: 26383162
[TBL] [Abstract][Full Text] [Related]
11. Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation Into Cancer and Nutrition (EPIC).
González CA; Jakszyn P; Pera G; Agudo A; Bingham S; Palli D; Ferrari P; Boeing H; del Giudice G; Plebani M; Carneiro F; Nesi G; Berrino F; Sacerdote C; Tumino R; Panico S; Berglund G; Simán H; Nyrén O; Hallmans G; Martinez C; Dorronsoro M; Barricarte A; Navarro C; Quirós JR; Allen N; Key TJ; Day NE; Linseisen J; Nagel G; Bergmann MM; Overvad K; Jensen MK; Tjonneland A; Olsen A; Bueno-de-Mesquita HB; Ocke M; Peeters PH; Numans ME; Clavel-Chapelon F; Boutron-Ruault MC; Trichopoulou A; Psaltopoulou T; Roukos D; Lund E; Hemon B; Kaaks R; Norat T; Riboli E
J Natl Cancer Inst; 2006 Mar; 98(5):345-54. PubMed ID: 16507831
[TBL] [Abstract][Full Text] [Related]
12. Is the association between Helicobacter pylori and gastric cancer confined to CagA-positive strains?
Held M; Engstrand L; Hansson LE; Bergström R; Wadström T; Nyrén O
Helicobacter; 2004 Jun; 9(3):271-7. PubMed ID: 15165264
[TBL] [Abstract][Full Text] [Related]
13. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection.
Parsonnet J; Friedman GD; Orentreich N; Vogelman H
Gut; 1997 Mar; 40(3):297-301. PubMed ID: 9135515
[TBL] [Abstract][Full Text] [Related]
14. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus.
Wu AH; Crabtree JE; Bernstein L; Hawtin P; Cockburn M; Tseng CC; Forman D
Int J Cancer; 2003 Mar; 103(6):815-21. PubMed ID: 12516104
[TBL] [Abstract][Full Text] [Related]
15. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori infection, chronic corpus atrophic gastritis and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort: A nested case-control study.
Huang J; Zagai U; Hallmans G; Nyrén O; Engstrand L; Stolzenberg-Solomon R; Duell EJ; Overvad K; Katzke VA; Kaaks R; Jenab M; Park JY; Murillo R; Trichopoulou A; Lagiou P; Bamia C; Bradbury KE; Riboli E; Aune D; Tsilidis KK; Capellá G; Agudo A; Krogh V; Palli D; Panico S; Weiderpass E; Tjønneland A; Olsen A; Martínez B; Redondo-Sanchez D; Chirlaque MD; Hm Peeters P; Regnér S; Lindkvist B; Naccarati A; Ardanaz E; Larrañaga N; Boutron-Ruault MC; Rebours V; Barré A; Bueno-de-Mesquita HB; Ye W
Int J Cancer; 2017 Apr; 140(8):1727-1735. PubMed ID: 28032715
[TBL] [Abstract][Full Text] [Related]
17. CagA protein seropositivity in a random sample of adult population and gastric cancer patients in Estonia.
Vorobjova T; Nilsson I; Kull K; Maaroos HI; Covacci A; Wadström T; Uibo R
Eur J Gastroenterol Hepatol; 1998 Jan; 10(1):41-6. PubMed ID: 9512952
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori and CagA status, serum gastrin, interleukin-8 and gastric acid secretion in gastric cancer.
Konturek SJ; Starzynska T; Konturek PC; Karczewska E; Marlicz K; Lawniczak M; Jaroszewicz-Heigelman H; Bielanski W; Hartwich A; Ziemniak A; Hahn EG
Scand J Gastroenterol; 2002 Aug; 37(8):891-8. PubMed ID: 12229962
[TBL] [Abstract][Full Text] [Related]
19. Multiplex serology of Helicobacter pylori antigens in detection of current infection and atrophic gastritis - A simple and cost-efficient method.
Shafaie E; Saberi S; Esmaeili M; Karimi Z; Najafi S; Tashakoripoor M; Abdirad A; Hosseini ME; Mohagheghi MA; Khalaj V; Mohammadi M
Microb Pathog; 2018 Jun; 119():137-144. PubMed ID: 29665437
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori seroprevalence in Spain: influence of adult and childhood sociodemographic factors.
Lorenzo I; Fernández-de-Larrea N; Michel A; Romero B; Lope V; Bessa X; Moreno V; Martín V; Amiano P; Castilla J; Tardón A; Dierssen-Sotos T; Peiró R; Díaz-Santos M; Navarro C; Jiménez-Moleón JJ; Butt J; Barricarte A; Ruiz I; Molina-de-la-Torre AJ; Casabonne D; Pérez-Gómez B; Kogevinas M; Del Campo R; de Sanjosé S; Pollán M; Waterboer T; Aragonés N
Eur J Cancer Prev; 2019 Jul; 28(4):294-303. PubMed ID: 30489354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
